Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The role of the adaptive immune response in controlling the growth and recurrence of human tumors has been controversial. We characterized the tumor-infiltrating immune cells in large cohorts of human colorectal cancers by gene expression profiling and in situ immunohistochemical staining. Collectively, the immunological data (the type, density, and location of immune cells within the tumor samples) were found to be a better predictor of patient survival than the histopathological methods currently used to stage colorectal cancer. The results were validated in two additional patient populations. These data support the hypothesis that the adaptive immune response influences the behavior of human tumors. In situ analysis of tumor-infiltrating immune cells may therefore be a valuable prognostic tool in the treatment of colorectal cancer and possibly other malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In CRC, Tregs situated in the tumor mesenchyme result in a better prognosis, whereas Tregs residing in the tumor nests and infiltrating margins are linked to unfavorable clinical outcomes [142, 143].”
From Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review (2024) · cites this paper as [142]
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
TNM Classification of Malignant Tumors
Carter, D. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199810000-00016 · Cited by 6,330
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
TNM Classification of Malignant Tumours
(2003) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471463752 · Cited by 3,946
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
Central Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance
Sallusto, F., Geginat, J., & Lanzavecchia, A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104702 · Cited by 3,067
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Research works printed but not linked: 3
- D. Pardoll, Nature411, 1010 (2001).
- Y. Naito et al., Cancer Res.58, 3491 (1998).
- We thank A. Rodi and M. Pelegrin for expert technical assistance; I. Gresser for helpful comments and critical review of the manuscript; and D. Frucht C. Anderson and T. Pokrovska for critically reading the manuscript. Supported by the Association pour la Recherche sur le Cancer (ARC) through the Alliance pour la Recherche sur le Cancer network (ARECA) INSERM Action Concertée Incitative ACI IMPBio Université Paris-Descartes Paris 5 and the Austrian Federal Ministry of Education Science and Culture (GBN-AU project Bioinformatics Integration Network).
Cited by
Items 701–800 of 1,043
Immune Checkpoints as a Target for Colorectal Cancer Treatment
Passardi, A., Canale, M., Valgiusti, M., & Ulivi, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061324 · Cited by 173
Katz, S. C., Bamboat, Z. M., Maker, A. V., Shia, J., Pillarisetty, V. G., Yopp, A. C., Hedvat, C. V., Gonen, M., Jarnagin, W. R., Fong, Y., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2668-9 · Cited by 171
Darrasse-Jèze, G., Bergot, A.-S., Durgeau, A., Billiard, F., Salomon, B. L., Cohen, J. L., Bellier, B., Podsypanina, K., & Klatzmann, D. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36628 · Cited by 138
Allavena, P., Chieppa, M., Bianchi, G., Solinas, G., Fabbri, M., Laskarin, G., & Mantovani, A. (2010) · Journal of Immunology Research · doi:10.1155/2010/547179 · Cited by 170
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain
Yegutkin, G. G., & Boison, D. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000528 · Cited by 170
Sanmamed, M. F., Rodriguez, I., Schalper, K. A., Oñate, C., Azpilikueta, A., Rodriguez-Ruiz, M. E., Morales-Kastresana, A., Labiano, S., Pérez-Gracia, J. L., Martín-Algarra, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3510 · Cited by 170
Roxburgh, C. S. D., Salmond, J. M., Horgan, P. G., Oien, K. A., & McMillan, D. C. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181a3e738 · Cited by 170
STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia
Curran, E., Chen, X., Corrales, L., Kline, D. E., Dubensky, T. W., Duttagupta, P., Kortylewski, M., & Kline, J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.023 · Cited by 170
Wilcox, R. A., Wada, D. A., Ziesmer, S. C., Elsawa, S. F., Comfere, N. I., Dietz, A. B., Novak, A. J., Witzig, T. E., Feldman, A. L., Pittelkow, M. R., et al. (2009) · Blood · doi:10.1182/blood-2009-05-220111 · Cited by 170
Benzon, B., Zhao, S. G., Haffner, M. C., Takhar, M., Erho, N., Yousefi, K., Hurley, P., Bishop, J. L., Tosoian, J., Ghabili, K., et al. (2017) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2016.49 · Cited by 170
Chheda, Z. S., Sharma, R. K., Jala, V. R., Luster, A. D., & Haribabu, B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502376 · Cited by 157
Lal, N., White, B. S., Goussous, G., Pickles, O., Mason, M. J., Beggs, A. D., Taniere, P., Willcox, B. E., Guinney, J., & Middleton, G. W. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1090 · Cited by 155
Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine
Ogino, S., Nowak, J. A., Hamada, T., Phipps, A. I., Peters, U., Milner Jr, D. A., Giovannucci, E. L., Nishihara, R., Giannakis, M., Garrett, W. S., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315537 · Cited by 169
Discovering dominant tumor immune archetypes in a pan-cancer census
Combes, A. J., Samad, B., Tsui, J., Chew, N. W., Yan, P., Reeder, G. C., Kushnoor, D., Shen, A., Davidson, B., Barczak, A. J., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.004 · Cited by 169
Neural innervation stimulates splenic TFF2 to arrest myeloid cell expansion and cancer
Dubeykovskaya, Z., Si, Y., Chen, X., Worthley, D. L., Renz, B. W., Urbanska, A. M., Hayakawa, Y., Xu, T., Westphalen, C. B., Dubeykovskiy, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms10517 · Cited by 169
Diffuse High Intensity PD–L1 Staining in Thymic Epithelial Tumors
Padda, S. K., Riess, J. W., Schwartz, E., Tian, L., Kohrt, H. E. K., Neal, J. W., West, R. B., & Wakelee, H. A. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000429 · Cited by 169
T-cell receptor-engineered T cells for cancer treatment: current status and future directions
Ping, Y., Liu, C., & Zhang, Y. (2018) · Protein & Cell · doi:10.1007/s13238-016-0367-1 · Cited by 157
Ijsselsteijn, M. E., van der Breggen, R., Farina Sarasqueta, A., Koning, F., & de Miranda, N. F. C. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02534 · Cited by 154
Wang, D., Cabalag, C. S., Clemons, N. J., & DuBois, R. N. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.09.059 · Cited by 169
Musolino, C., Allegra, A., Innao, V., Allegra, A. G., Pioggia, G., & Gangemi, S. (2017) · Mediators of Inflammation · doi:10.1155/2017/1852517 · Cited by 168
Quaranta, V., Rainer, C., Nielsen, S. R., Raymant, M. L., Ahmed, M. S., Engle, D. D., Taylor, A., Murray, T., Campbell, F., Palmer, D. H., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3876 · Cited by 168
Watanabe, Y., Katou, F., Ohtani, H., Nakayama, T., Yoshie, O., & Hashimoto, K. (2010) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2009.12.015 · Cited by 168
NF-κB Directly Regulates Fas Transcription to Modulate Fas-mediated Apoptosis and Tumor Suppression
Liu, F., Bardhan, K., Yang, D., Thangaraju, M., Ganapathy, V., Waller, J. L., Liles, G. B., Lee, J. R., & Liu, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356279 · Cited by 168
Epardaud, M., Elpek, K. G., Rubinstein, M. P., Yonekura, A.-R., Bellemare-Pelletier, A., Bronson, R., Hamerman, J. A., Goldrath, A. W., & Turley, S. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0045 · Cited by 167
Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes
Bellone, M., & Calcinotto, A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00231 · Cited by 167
The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology
Finkelstein, S. E., Timmerman, R., McBride, W. H., Schaue, D., Hoffe, S. E., Mantz, C. A., & Wilson, G. D. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/439752 · Cited by 167
HPV Carcinomas in Immunocompromised Patients
Reusser, N. M., Downing, C. P., Guidry, J. A., & Tyring, S. K. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4020260 · Cited by 167
Adoptive immunotherapy for cancer
Ruella, M., & Kalos, M. D. (2013) · Immunological Reviews · doi:10.1111/imr.12136 · Cited by 167
An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer
Karasaki, T., Nagayama, K., Kuwano, H., Nitadori, J., Sato, M., Anraku, M., Hosoi, A., Matsushita, H., Morishita, Y., Kashiwabara, K., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.01.005 · Cited by 167
Edin, S., Kaprio, T., Hagström, J., Larsson, P. G., Mustonen, H. K., Böckelman, C., Strigård, K., Gunnarsson, U., Haglund, C. H., & Palmqvist, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-56441-8 · Cited by 167
A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy
Deschoolmeester, V., Baay, M., Specenier, P., Lardon, F., & Vermorken, J. B. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-0025 · Cited by 166
Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity
Anagnostou, V., Yarchoan, M., Hansen, A. R., Wang, H., Verde, F., Sharon, E., Collyar, D., Chow, L. Q. M., & Forde, P. M. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3065 · Cited by 166
Wimmers, F., Schreibelt, G., Sköld, A. E., Figdor, C. G., & De Vries, I. J. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00165 · Cited by 148
Tang, M., Diao, J., Gu, H., Khatri, I., Zhao, J., & Cattral, M. S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.053 · Cited by 152
Pagès, F., André, T., Taieb, J., Vernerey, D., Henriques, J., Borg, C., Marliot, F., Ben Jannet, R., Louvet, C., Mineur, L., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.310 · Cited by 155
Self-citationLin, J.-R., Chen, Y.-A., Campton, D., Cooper, J., Coy, S., Yapp, C., Tefft, J. B., McCarty, E., Ligon, K. L., Rodig, S. J., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00576-1 · Cited by 165
Shimizu, S., Hiratsuka, H., Koike, K., Tsuchihashi, K., Sonoda, T., Ogi, K., Miyakawa, A., Kobayashi, J., Kaneko, T., Igarashi, T., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.1889 · Cited by 165
Wang, B., Wu, S., Zeng, H., Liu, Z., Dong, W., He, W., Chen, X., Dong, X., Zheng, L., Lin, T., et al. (2015) · Journal of Urology · doi:10.1016/j.juro.2015.02.2941 · Cited by 165
Betts, G., Jones, E., Junaid, S., El-Shanawany, T., Scurr, M., Mizen, P., Kumar, M., Jones, S., Rees, B., Williams, G., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300970 · Cited by 165
Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
Zeestraten, E. C. M., Reimers, M. S., Saadatmand, S., Dekker, J.-W. T., Liefers, G. J., van den Elsen, P. J., van de Velde, C. J. H., & Kuppen, P. J. K. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.696 · Cited by 165
Immune Checkpoint Inhibitor Combinations in Solid Tumors: Opportunities and Challenges
Kyi, C., & Postow, M. A. (2016) · Immunotherapy · doi:10.2217/imt-2016-0002 · Cited by 165
Tumor Infiltrating Immune Cells and Outcome of Merkel Cell Carcinoma: A Population-Based Study
Sihto, H. J., Böhling, T., Kavola, H., Koljonen, V., Salmi, M., Jalkanen, S., & Joensuu, H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3020 · Cited by 165
The immunologic constant of rejection
Wang, E., Worschech, A., & Marincola, F. M. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.03.002 · Cited by 165
Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters
Dauer, P., Nomura, A., Saluja, A., & Banerjee, S. (2016) · Pancreatology · doi:10.1016/j.pan.2016.12.010 · Cited by 165
Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients
Xing, X., Guo, J., Ding, G., Li, B., Dong, B., Feng, Q., Li, S., Zhang, J., Ying, X., Cheng, X., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1356144 · Cited by 145
Gemta, L. F., Siska, P. J., Nelson, M. E., Gao, X., Liu, X., Locasale, J. W., Yagita, H., Slingluff, C. L., Hoehn, K. L., Rathmell, J. C., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aap9520 · Cited by 155
Why is melanoma so metastatic?
Braeuer, R. R., Watson, I. R., Wu, C., Mobley, A. K., Kamiya, T., Shoshan, E., & Bar‐Eli, M. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12172 · Cited by 164
Richards, C. H., Mohammed, Z., Qayyum, T., Horgan, P. G., & McMillan, D. C. (2011) · Future Oncology · doi:10.2217/fon.11.99 · Cited by 164
B Cells Promote Tumor Progression via STAT3 Regulated-Angiogenesis
Yang, C., Lee, H., Pal, S., Jove, V., Deng, J., Zhang, W., Hoon, D. S. B., Wakabayashi, M., Forman, S., & Yu, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064159 · Cited by 164
Use of tumour-responsive T cells as cancer treatment
Disis, M. L., Bernhard, H., & Jaffee, E. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60404-9 · Cited by 164
Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting
(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2018.12.002 · Cited by 164
The Gastrointestinal Tumor Microenvironment
Quante, M., Varga, J., Wang, T. C., & Greten, F. R. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.03.052 · Cited by 151
Shaping Up the Tumor Microenvironment With Cellular Fibronectin
Efthymiou, G., Saint, A., Ruff, M., Rekad, Z., Ciais, D., & Obberghen‐Schilling, E. V. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00641 · Cited by 164
Harnessing the chemokine system to home CAR-T cells into solid tumors
Foeng, J., Comerford, I., & McColl, S. R. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100543 · Cited by 169
Toll-like receptors and immune regulation: implications for cancer therapy
Wang, R.-F., Miyahara, Y., & Wang, H. Y. (2008) · Oncogene · doi:10.1038/sj.onc.1210906 · Cited by 163
Cancer immune escape: MHC expression in primary tumours versus metastases
Garrido, F., & Aptsiauri, N. (2019) · Immunology · doi:10.1111/imm.13114 · Cited by 163
The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling
Stockmann, C., Schadendorf, D., Klose, R., & Helfrich, I. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00069 · Cited by 163
Melaiu, O., Chierici, M., Lucarini, V., Jurman, G., Conti, L. A., De Vito, R., Boldrini, R., Cifaldi, L., Castellano, A., Furlanello, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19781-y · Cited by 163
Krijgsman, D., de Vries, N. L., Skovbo, A., Andersen, M. N., Swets, M., Bastiaannet, E., Vahrmeijer, A. L., van de Velde, C. J. H., Heemskerk, M. H. M., Hokland, M., et al. (2019) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-019-02343-7 · Cited by 163
Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer
Kang, C.-W., Dutta, A., Chang, L.-Y., Mahalingam, J., Lin, Y.-C., Chiang, J.-M., Hsu, C.-Y., Huang, C.-T., Su, W.-T., Chu, Y.-Y., et al. (2015) · Scientific Reports · doi:10.1038/srep15659 · Cited by 163
Bhattacharya, N., Yuan, R., Prestwood, T. R., Penny, H. L., DiMaio, M. A., Reticker-Flynn, N. E., Krois, C. R., Kenkel, J. A., Pham, T. D., Carmi, Y., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.08.008 · Cited by 163
Torrens, L., Montironi, C., Puigvehí, M., Mesropian, A., Leslie, J., Haber, P. K., Maeda, M., Balaseviciute, U., Willoughby, C. E., Abril‐Fornaguera, J., et al. (2021) · Hepatology · doi:10.1002/hep.32023 · Cited by 163
Shia, J., Black, D., Hummer, A. J., Boyd, J., & Soslow, R. A. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.05.022 · Cited by 163
Immune Response and the Tumor Microenvironment: How They Communicate to Regulate Gastric Cancer
Lee, K., Hwang, H., & Nam, K. T. (2014) · Gut and Liver · doi:10.5009/gnl.2014.8.2.131 · Cited by 163
Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma
Mina, M., Boldrini, R., Citti, A., Romania, P., D’Alicandro, V., Ioris, M. A. D., Castellano, A., Furlanello, C., Locatelli, F., & Fruci, D. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1019981 · Cited by 163
Zumwalt, T. J., Arnold, M., Goel, A., & Boland, C. R. (2015) · Oncotarget · doi:10.18632/oncotarget.3205 · Cited by 151
Wong, J. L., Berk, E., Edwards, R. P., & Kaliński, P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4366 · Cited by 163
Efstathiou, J. A., Mouw, K. W., Gibb, E. A., Liu, Y., Wu, C., Drumm, M. R., da Costa, J. B., du Plessis, M., Wang, N. Q., Davicioni, E., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.01.011 · Cited by 163
Chen, S., Feng, S., Wei, J., Liu, F., Li, B., Li, X., Hou, Y., Gu, D., Tang, M., Xiao, H., et al. (2019) · European Radiology · doi:10.1007/s00330-018-5986-x · Cited by 163
Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer
Wang, S., Zhang, Q., Yu, C., Cao, Y., Zuo, Y., & Yang, L. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa026 · Cited by 163
An introduction to multiparameter persistence
Botnan, M. B., & Lesnick, M. (2023) · EMS series of congress reports · doi:10.4171/ecr/19/4 · Cited by 163
Next-generation computational tools for interrogating cancer immunity
Finotello, F., Rieder, D., Hackl, H., & Trajanoski, Z. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0166-7 · Cited by 162
Self-citationLee, H. J., Park, I. A., Song, I. H., Shin, S.-J., Kim, J. Y., Yu, J. H., & Gong, G. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-203089 · Cited by 162
Learning to detect lymphocytes in immunohistochemistry with deep learning
Swiderska-Chadaj, Z., Pinckaers, H., van Rijthoven, M., Balkenhol, M., Melnikova, M., Geessink, O., Manson, Q., Sherman, M., Polonia, A., Parry, J., et al. (2019) · Medical Image Analysis · doi:10.1016/j.media.2019.101547 · Cited by 162
Report From the Jerusalem Workshop on Lynch Syndrome-Hereditary Nonpolyposis Colorectal Cancer
Boland, C. R., & Shike, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.024 · Cited by 162
Klinger, M., Benjamin, J., Kischel, R., Stienen, S., & Zugmaier, G. (2016) · Immunological Reviews · doi:10.1111/imr.12393 · Cited by 156
Linking Gut Microbiota to Colorectal Cancer
Raskov, H., Burcharth, J., & Pommergaard, H.-C. (2017) · Journal of Cancer · doi:10.7150/jca.20497 · Cited by 146
Mesker, W. E., Liefers, G.-J., Junggeburt, J. M. C., van Pelt, G. W., Alberici, P., Kuppen, P. J. K., Miranda, N. F., van Leeuwen, K. A. M., Morreau, H., Szuhai, K., et al. (2009) · Analytical Cellular Pathology · doi:10.1155/2009/214085 · Cited by 140
Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity
Germain, C., Gnjatic, S., & Dieu-Nosjean, M.-C. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00067 · Cited by 161
Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer
Herter-Sprie, G. S., Koyama, S., Korideck, H., Hai, J., Deng, J., Li, Y. Y., Buczkowski, K. A., Grant, A. K., Ullas, S., Rhee, K., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87415 · Cited by 161
Lymph node harvest in colon and rectal cancer: Current considerations
McDonald, J. T., Renehan, A. G., O'Dwyer, S. T., & Haboubi, N. Y. (2012) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v4.i1.9 · Cited by 161
The Role of Chronic Inflammation in Obesity-Associated Cancers
Ramos-Nino, M. E. (2013) · ISRN Oncology · doi:10.1155/2013/697521 · Cited by 127
Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer
Mileo, A. M., Nisticò, P., & Miccadei, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00729 · Cited by 160
Sparse autoencoder for unsupervised nucleus detection and representation in histopathology images
Hou, L., Nguyen, V., Kanevsky, A. B., Samaras, D., Kurc, T. M., Zhao, T., Gupta, R. R., Gao, Y., Chen, W., Foran, D., et al. (2019) · Pattern Recognition · doi:10.1016/j.patcog.2018.09.007 · Cited by 160
Pruneri, G., Vingiani, A., Bagnardi, V., Rotmensz, N., De Rose, A., Palazzo, A., Colleoni, A. M., Goldhirsch, A., & Viale, G. (2016) · Annals of Oncology · doi:10.1093/annonc/mdv571 · Cited by 160
Singer, K., Kastenberger, M., Gottfried, E., Hammerschmied, C. G., Büttner, M., Aigner, M., Seliger, B., Walter, B., Schlösser, H., Hartmann, A., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25543 · Cited by 160
Blykers, A., Schoonooghe, S., Xavier, C., D’hoe, K., Laoui, D., D’Huyvetter, M., Vaneycken, I., Cleeren, F., Bormans, G., Heemskerk, J., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.156828 · Cited by 160
“correlates with a worse prognosis in multiple tumor types (20,21).”
BackgroundD’Amico, L., Mahajan, S., Capietto, A.-H., Yang, Z., Zamani, A., Ricci, B., Bumpass, D. B., Meyer, M., Su, X., Wang-Gillam, A., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20150950 · Cited by 160
B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma
Zhou, Z., Luther, N., Ibrahim, G. M., Hawkins, C. E., Vibhakar, R., Handler, M. H., & Souweidane, M. M. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-1021-2 · Cited by 160
Immunosurveillance and therapy of multiple myeloma are CD226 dependent
Guillerey, C., Ferrari de Andrade, L., Vuckovic, S., Miles, K., Ngiow, S. F., Yong, M. C. R., Teng, M. W. L., Colonna, M., Ritchie, D. S., Chesi, M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77181 · Cited by 152
Cammarota, R., Bertolini, V., Pennesi, G., Bucci, E. O., Gottardi, O., Garlanda, C., Laghi, L., Barberis, M. C. P., Sessa, F., Noonan, D. M., et al. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-112 · Cited by 160
Antagonism of the STING Pathway via Activation of the AIM2 Inflammasome by Intracellular DNA
Corrales, L., Woo, S.-R., Williams, J. B., McWhirter, S. M., Dubensky, T. W., & Gajewski, T. F. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502538 · Cited by 146
Biomarkers for Immunotherapy: Current Developments and Challenges
Spencer, K. R., Wang, J., Silk, A. W., Ganesan, S., Kaufman, H. L., & Mehnert, J. M. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_160766 · Cited by 160
Opzoomer, J. W., Sosnowska, D., Anstee, J. E., Spicer, J. F., & Arnold, J. N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01654 · Cited by 152
Long-distance modulation of bystander tumor cells by CD8+ T-cell-secreted IFN-γ
Hoekstra, M. E., Bornes, L., Dijkgraaf, F. E., Philips, D., Pardieck, I. N., Toebes, M., Thommen, D. S., van Rheenen, J., & Schumacher, T. N. (2020) · Nature Cancer · doi:10.1038/s43018-020-0036-4 · Cited by 161
MCT4 blockade increases the efficacy of immune checkpoint blockade
Babl, N., Decking, S.-M., Voll, F., Althammer, M., Sala-Hojman, A., Ferretti, R., Korf, C., Schmidl, C., Schmidleithner, L., Nerb, B., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007349 · Cited by 161
Brown, J. R., Wimberly, H., Lannin, D. R., Nixon, C., Rimm, D. L., & Bossuyt, V. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1622 · Cited by 159
Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy
Li, J., Eu, J. Q., Kong, L. R., Wang, L., Lim, Y. C., Goh, B. C., & Wong, A. L. A. (2020) · Molecules · doi:10.3390/molecules25204831 · Cited by 159
Berghuis, D., Santos, S. J., Baelde, H. J., Taminiau, A. H., Maarten Egeler, R., Schilham, M. W., Hogendoorn, P. C., & Lankester, A. C. (2011) · The Journal of Pathology · doi:10.1002/path.2819 · Cited by 159
Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2015.05.001 · Cited by 159
Metadata
- Authors
- Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., Zinzindohoué, F., Bruneval, P., Cugnenc, P.-H., Trajanoski, Z., Fridman, W.-H., & Pagès, F.
- Affiliations
- INSERM U 255, Paris, 75006 France; Université Paris-Descartes Paris 5, Faculté de Médecine, Paris, 75006 France; and Université Pierre et Marie Curie Paris 6, Institut des Cordeliers, Paris, 75006 France.
- Inserm (FR)
- ORCID
- Venue
- Science
- Published
- 2006-09-29
- Volume
- 313
- Issue
- 5795
- Pages
- 1960-1964
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2142300779
- Cited by
- 6,516
- References
- 31
- Citations by year
- 2026: 237 · 2025: 278 · 2024: 329 · 2023: 444 · 2022: 451 · 2021: 574 · 2020: 524 · 2019: 433 · 2018: 447 · 2017: 405 · 2016: 394 · 2015: 380 · 2014: 268 · 2013: 282 · 2012: 237
- FWCI
- 70.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Keywords
- colorectal cancer, tumor-infiltrating immune cells, adaptive immune response, prognostic factors, patient survival, tumor immune microenvironment, gene expression profiling, cancer immunotherapy
- MeSH terms
- Female, Humans, Immunohistochemistry, Immunologic Memory, Lymphatic Metastasis, Male, Neoplasm Invasiveness, Neoplasm Recurrence, Local, Neoplasm Staging, Prognosis, Colorectal Neoplasms, Cohort Studies, Survival Analysis, Polymerase Chain Reaction, T-Lymphocyte Subsets, Lymphocytes, Tumor-Infiltrating, CD3 Complex, Leukocyte Common Antigens, CD8-Positive T-Lymphocytes, Th1 Cells, Disease Progression, Disease-Free Survival, Lymphocyte Count, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.